Healthcare

Global Induced Pluripotent Stem Cells Market Report: Regional Data Analysis by Production, Revenue, Price and Gross Margin Forecast to 2026

Global induced pluripotent stem cells market is expected to rise to an estimated value of USD 2610.10 million by 2026, registering a substantial CAGR of 8.35% in the forecast period of 2019-2026. Rising prevalence for critical care services which is the major factor for the growth of this market.

Global Induced Pluripotent Stem Cells Market By Cell Type (Hepatocytes, Fibroblasts, Keratinocytes, Amniotic Cells, Neurons, Others), Application (Drug Development, Regenerative Medicine, Toxicity Testing, Academic Research), End-User (Academic and Research Institutes, Biotechnology Companies, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends & Forecast to 2026.

Request for Free Sample [email protected]https://databridgemarketresearch.com/reports/global-induced-pluripotent-stem-cells-market

Market Analysis: Global Induced Pluripotent Stem Cells Market 

Global induced pluripotent stem cells market is expected to rise to an estimated value of USD 2610.10 million by 2026, registering a substantial CAGR of 8.35% in the forecast period of 2019-2026. Rising prevalence for critical care services which is the major factor for the growth of this market.

Market Definition: Global Induced Pluripotent Stem Cells Market 

Induced pluripotent stem cells are type of the pluripotent cells which are usually formed by the adult cells which is used to repair the damages tissues in the body. These cells are obtained from the children or adult which is later modified so that it can be used as induced pluripotent stem cells. Hepatocytes, amniotic cells, neurons, keratinocytes, fibroblast are some of the most common type of the cells. Rising cases of chronic diseases is the major factor fueling the growth of this market.

Market Drivers

  • Rising geriatric population is driving the growth of this market
  • Increasing chronic diseases among population is another factor driving the growth of this market
  • Increasing investment in R&D of induced pluripotent stem cells is driving the market growth

Market Restraints

  • High cost related to the reprograming of cells is the major factor restraining the market growth
  • Increasing chances of the tumor is another factor restraining the market growth

Segmentation: Global Induced Pluripotent Stem Cells Market 

By Cell Type

  •  Hepatocytes
  •  Fibroblasts
  •  Keratinocytes
  •  Amniotic Cells
  •  Neurons
  •  Others

By Application

  •  Drug Development
  •  Regenerative Medicine
  •  Toxicity Testing
  •  Academic Research

By End-User

  •  Academic and Research Institutes
  •  Biotechnology Companies
  •  Others

Key Developments in the Market:

  • In March 2018, Kaneka Corporation announced that they have acquired a patent in the Japan for the creation of the method to mass-culture pluripotent stem cells including iPS cells and ES cells. This will help the company to use the technology to produce high quality pluripotent stem cells which can be used in the drug and cell therapy.
  • In March 2015, Fujifilm announced that they have acquired Cellular Dynamics International. The main aim of the acquisition is to expand their business in the iPS cell-based drug discovery support service with the use of CDS technology. It will help them to product high- quality automatic human cells with the help of the induced pluripotent stem cells. This will help the company to be more competitive in the drug discovery and regenerative medicine.

Competitive Analysis: Global Induced Pluripotent Stem Cells Market 

Global induced pluripotent stem cells market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of induced pluripotent stem cells market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.

Request for [email protected] https://www.databridgemarketresearch.com/toc?dbmr=global-induced-pluripotent-stem-cells-market

Key Market Competitors: Global Induced Pluripotent Stem Cells Market  

Few of the major competitors currently working in global induced pluripotent stem cells market are FUJIFILM Holdings Corporation, Astellas Pharma Inc, Fate Therapeutics, Bristol-Myers Squibb Company, ViaCyte, Inc., CELGENE CORPORATION, Vericel Corporation, KCI Licensing, Inc, STEMCELL Technologies Inc., Japan Tissue Engineering Co., Ltd., Organogenesis Holdings Inc, Lonza, Takara Bio Inc., Horizon Discovery Group plc, Thermo Fisher Scientific.

About Us
Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others.

Contact Us
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Mail: [email protected]

Report Rating
Close